Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drug Manufacturers - Other Sector (CIX: MSECTOR511)
2,249.95   -18.65 (-0.82%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Sector News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Open 2262.22
Prev. Close 2268.60
Today's Range 2239.35 - 2283.21
52wk Range 1681.64 - 2312.97
Components
View All
Value % Change
Novo Nordisk A/S ADS  171.68
-0.18%
Teva Pharmaceutical Industries  40.19
-0.10%
Allergan, Inc.  98.50
-2.87%
Alexion Pharmaceuticals, Inc.  100.03
-2.79%
Shire pic  95.28
+1.98%
Vertex Pharmaceuticals, Inc.  77.38
-2.65%
Forest Laboratories, Inc.  37.98
-1.43%
Dr. Reddys Laboratories Ltd. ADS  37.66
-0.71%
Pharmacyclics, Inc.  81.86
-3.57%
Endo Pharmaceuticals Holdings  33.73
-1.89%
Top News
More News
U.S. court ruling favors Cubist in patent case versus Hospira
May 20, 2013
A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . Read More
from FOX News
U.S. court ruling favors Cubist in patent case vs Hospira
May 20, 2013
May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin... Read More
from Reuters: Company News
Interesting OPK Put And Call For July
May 20, 2013
Investors in Opko Health Inc (OPK) saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the... Read More
from Market News Video
More News
More News
Pfizer halts study of lymphoma drug unlikely to help survival
May 20, 2013
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive... Read More
from Reuters: Company News
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
Medium and large sized pharmaceutical companies were down by an average of .3-.6% at the closing bell Jumps by % Gain and Mkt Cap Change Biolife Solutions (OTC: BLFS) +34% on spike in trading activity... Read More
from Bio-Wire.Com
UPDATE: Cubist Pharmaceuticals (CBST) Spikes to Session Highs
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8354934 for the full story. Read More
from StreetInsider.com News Articles
Bearish Moving Average Cross by Forest Laboratories (FRX)
May 20, 2013
from Comtex SmarTrend® News Briefs
Enteromedics Rallies On Confirmed Path To Possible Approval
May 20, 2013
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity... Read More
from Bio-Wire.Com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here